In the case of activation with exogenous PAg added to IL-2, PBMC of CLL patients showed a significant ex vivo expansion of Vδ2 T cells with the ability to secrete lytic granules leading to the efficient killing of autologous CLL cells (62). Here, IL2 is linked to B-cell chronic lymphocytic leukemia.